The human brain develops through an intricate balance of cellular growth, connectivity, and metabolism. A new study reveals that a single metabolic enzyme, glutamine synthetase (GS), plays a decisive role in shaping brain circuits after birth by directing astrocyte maturation and neuronal connectivity in the cerebral cortex.
GS converts glutamate into glutamine, a molecule essential for neurotransmitter recycling and amino-acid balance. Although GS is known to protect the adult brain from neurodegeneration, its role during early brain development has remained unclear. Using genetically engineered mice lacking GS specifically in the cerebral cortex, researchers uncovered a critical postnatal function for this enzyme.
The team found that GS is highly expressed in neural stem cells before birth and later becomes enriched in astrocytes—support cells that guide synapse formation and circuit refinement. Surprisingly, deleting GS did not disrupt embryonic neurogenesis or neuronal migration. Instead, the most profound effects emerged after birth, when astrocytes failed to mature properly. These defective astrocytes showed abnormal morphology, reduced expression of key developmental markers, and eventually became reactive, a hallmark of brain inflammation.
At the molecular level, loss of GS disrupted amino-acid homeostasis and selectively suppressed the mTOR signaling pathway, a central regulator of cellular growth and metabolism. This suppression impaired astrocytic metabolic support to neurons, leading to stunted dendritic growth, reduced synapse formation, and weakened neural activity. As a result, mice exhibited behavioral abnormalities in motor coordination and social interaction—features relevant to neurodevelopmental disorders such as epilepsy and autism.
Importantly, providing dietary glutamine partially rescued astrocyte maturation and synaptic deficits, highlighting a direct metabolic link between GS activity and brain circuit development.
Together, these findings identify GS as a key metabolic regulator of postnatal cortical maturation. By linking astrocyte metabolism to mTOR signaling and neural connectivity, the study offers new insight into how metabolic dysfunction can drive neurodevelopmental disorders and suggests that targeting astrocytic metabolism may open new therapeutic avenues.
10.1093/procel/pwaf112